Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Interest Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Interest Expenses for 3 consecutive years, with $1.9 million as the latest value for Q1 2026.

  • Quarterly Interest Expenses rose 5.89% to $1.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Jan 2026, down 5.66% year-over-year, with the annual reading at $7.7 million for FY2025, 24.14% up from the prior year.
  • Interest Expenses for Q1 2026 was $1.9 million at Kestra Medical Technologies, down from $1.9 million in the prior quarter.
  • The five-year high for Interest Expenses was $2.3 million in Q4 2024, with the low at $1.7 million in Q1 2024.
  • Average Interest Expenses over 3 years is $1.9 million, with a median of $1.9 million recorded in 2026.
  • Peak annual rise in Interest Expenses hit 8.0% in 2025, while the deepest fall reached 17.95% in 2025.
  • Over 3 years, Interest Expenses stood at $2.3 million in 2024, then dropped by 17.95% to $1.9 million in 2025, then dropped by 0.68% to $1.9 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $1.9 million, $1.9 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.